Splash Beverage Group faces NYSE compliance issues and plans to submit a corrective action plan while pursuing a merger with Medterra.
Quiver AI Summary
Splash Beverage Group, Inc. announced that it has received notice from NYSE Regulation regarding non-compliance with the exchange's minimum shareholders' equity standards, requiring the company to submit a compliance plan by May 29, 2026. If accepted, the plan could grant the company until January 29, 2027, to meet the listing requirements. Board member Brady Cobb emphasized the company’s commitment to improving its financial stability and compliance. Additionally, the company is exploring a potential merger with Medterra CBD, LLC, with terms already agreed upon, contingent on further due diligence and the execution of definitive agreements. Existing uncertainties and risks could affect the completion of this merger and compliance with listing requirements.
Potential Positives
- The company has taken proactive steps by outlining a plan to regain compliance with NYSE listing standards, demonstrating accountability and transparency to shareholders.
- A potential business combination with Medterra CBD could expand Splash Beverage's product offerings and market presence in the rapidly growing cannabinoid wellness sector.
- Management's focus on strengthening the company's balance sheet and building a more resilient enterprise indicates a commitment to long-term growth and stability.
Potential Negatives
- The company is currently not in compliance with the NYSE’s continued listing standards related to minimum shareholders’ equity, which could jeopardize its listing on the exchange.
- Failure to submit an acceptable plan to regain compliance by the deadline may lead to further sanctions from the NYSE.
- The need for a business combination with Medterra, while potentially beneficial, suggests that the company is in a precarious financial position and may lack stability on its own.
FAQ
What is the recent compliance issue faced by Splash Beverage Group?
Splash Beverage Group received a notice from NYSE regarding non-compliance with minimum shareholders’ equity requirements.
What steps is Splash Beverage Group taking to regain compliance?
The Company is preparing a plan to address compliance issues, focused on strengthening the balance sheet and transparency.
What is the proposed merger with Medterra CBD?
Splash entered a letter of intent with Medterra for a potential business combination, pending due diligence and further agreements.
What is the deadline for Splash to submit its compliance plan?
The compliance plan must be submitted to NYSE by May 29, 2026.
How could the merger with Medterra impact NYSE listing requirements?
The merger may help Splash regain compliance with NYSE standards, contingent on meeting various conditions and approvals.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SBEV Revenue
$SBEV had revenues of $-3.5M in Q4 2025. This is an increase of 421.42% from the same period in the prior year.
You can track SBEV financials on Quiver Quantitative's SBEV stock page.
$SBEV Hedge Fund Activity
We have seen 10 institutional investors add shares of $SBEV stock to their portfolio, and 8 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PHRACTION MANAGEMENT LLC added 70,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $25,147
- UBS GROUP AG added 38,016 shares (+251.8%) to their portfolio in Q1 2026, for an estimated $13,657
- TRUIST FINANCIAL CORP added 32,819 shares (+inf%) to their portfolio in Q1 2026, for an estimated $11,790
- TWO SIGMA SECURITIES, LLC added 22,119 shares (+inf%) to their portfolio in Q4 2025, for an estimated $15,270
- CITADEL ADVISORS LLC added 14,126 shares (+113.7%) to their portfolio in Q4 2025, for an estimated $9,752
- GEODE CAPITAL MANAGEMENT, LLC added 13,928 shares (+inf%) to their portfolio in Q4 2025, for an estimated $9,615
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 13,785 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $9,517
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
Full Release
FORT LAUDERDALE, Fla., May 05, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), today announced that on April 29, 2026, it received a notice from NYSE Regulation (the “NYSE”) indicating that the Company is not currently in compliance with the NYSE’s continued listing standards related to minimum shareholders’ equity. In accordance with NYSE requirements, the Company is required to submit a plan by May 29, 2026, outlining the actions it has taken or will take to regain compliance. If the plan is accepted, the Company may be granted a cure period extending through January 29, 2027 to restore compliance with the continued listing standards.
Management Commentary
“Since stepping into this new phase of leadership, our priority has been to bring discipline, transparency, and a rigorous compliance framework to the organization,” said Brady Cobb, Board member of Splash. “We are taking decisive steps to strengthen our balance sheet and align the Company with NYSE standards. Our focus is not just on regaining compliance, but on building a more resilient and accountable enterprise for the long term.”
As previously announced, the Company entered into a letter of intent (the “Letter”) with Medterra CBD, LLC (“Medterra”), a leading manufacturer and multi-brand operator of federally compliant cannabinoid wellness products. The parties agreed in principal on the terms of a potential business combination between Medterra and the Company (the “Merger”), which the Merger would be subject to further due diligence and execution of a definitive Merger Agreement and other applicable agreements, including shareholder approval, and customary closing conditions. The Company has delivered a draft of the proposed Merger Agreement to Medterra and is awaiting comments.
More information
:
https://splashbeveragegroup.com
Contact Information:
Splash Beverage Group 954-745-5815 [email protected]
Dennis Burns 567-237-4132 [email protected]
Media Contact:
Angela Gorman
[email protected]
917.348.0083
Cautionary Note Regarding Forward-Looking Statements:
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the closing of a potential business combination with Medterra and whether the NYSE will find that the proposed business combination complies with their listing requirements. Forward-looking statements are prefaced by words such as “anticipate,” “expect,” “plan,” “could,” “may,” “will,” “should,” “would,” “intend,” “seem,” “potential,” “appear,” “continue,” “future,” believe,” “estimate,” “forecast,” “project,” and similar words. Forward-looking statements are based on our current expectations and assumptions regarding our business and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. We caution you, therefore, against relying on any of these forward-looking statements. Our actual results may differ materially from those contemplated by the forward-looking statements for a variety of reasons, including, without limitation, our ability to negotiate and enter into a definitive Merger Agreement, our need to raise sufficient capital to repay Medterra’s indebtedness which will be a condition to closing and additional funding to meet our working capital needs, our ability to reach an agreement with Medterra’s lender on the value of certain warrants, the need for consents and approvals from third parties to proceed with the transaction and any risks and uncertainties which may arise from any failure to obtain such consents and approvals, our ability to convince the NYSE that we will meet its listing requirement upon the closing of the proposed business combination. See also the Risk Factors contained in our Form 10-K for the year ended December 31, 2025. Any forward-looking statement made by us in this presentation speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.